Report Categories
View AllRecent Articles
View All
BCARW BoralARCWrt key quarterly earnings metrics remain undisclosed as the firm finalizes formal financial reporting
SSL Sasol Ltd beats Q1 estimates but shares drop 3 as investors eye uncertain outlook
Media Conglomerate Leadership Test Amid Partisan Content Pressure
MNYWW MoneyHero withholds quarterly earnings metrics as it refocuses on nearterm core fintech expansion priorities
Anthropic Secondary Market Heats Up Amid Fraud Concerns
China Confirms Order for 200 Boeing Aircraft Signals Aviation as Key Cooperation Area with US
Pure Storage Reports Robust Q1 2027 Performance Shares Decline on Guidance
Gold Rally Hinges on Clearer Fed Rate Cut Signals Market Observers Say
Northland Adjusts SoundHound AI Price Target Maintains Outperform Rating Amid Q1 Results
US Iran Signal Progress on Middle East Peace But Remain Divided Over Uranium Enrichment and Strait of Hormuz Tolls
Bowhead Specialty Holdings Inc BOW Q1 2026 Earnings Strong EPS Beat Driven by Robust Underwriting Performance
ATEX Q1 2026 Earnings Narrower Loss Beats Estimates as Strategic Momentum Builds
First National Corporation FXNC Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain
APH Q1 2026 Earnings EPS Beats Estimates by 113 Stock Edges Higher
Nortech Systems NSYS Q3 2025 Earnings Loss Per Share Reported Amid Modest Stock Gain
HWM Q1 2026 Earnings EPS Surprises to the Upside as Aerospace Demand Remains Robust
Blueport Acquisition Ltd BPAC Holds Steady Near 1009 Amid SPAC Market Consolidation
Editas Medicine EDIT Surges 5 GeneEditing Stock Tests Key Resistance Amid Renewed Momentum
Space Asset Acquisition Corp SAAQ Edges Higher Amid Quiet Trading Key Levels in Focus
BNY Mellon High Yield Strategies Fund DHF Edges Higher Amid Stable Trading
Madison Square Garden Entertainment MSGE Holds Steady at 695 Testing Key Resistance Levels
Spruce Power Holding SPRU Holds Steady Near Support A Test of Resilience
CGI Inc GIB Rallies 145 as Shares Test Resistance Near 70
PennyMac Financial Services PFSI Edges Higher Key Levels in Focus
Zymeworks ZYME Shares Slip 24 Testing Support Near 2355
USGOW Plunges 34 as Warrant Trading Faces Sharp Decline